QC and Release Testing of Vector and Cell Clinical Gene Therapy Products
Description preview
The release of clinical vector/virus and cell products requires the execution of several concurrent, time sensitive assays by the Surgery Branch Quality Control Unit. These assays demonstrate appropriate conformance to specification metrics of products manufactured both at the Surgery Branch and from external labs such as Contract Manufacturing…
Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click